CCM
PACB icon

Covington Capital Management’s Pacific Biosciences PACB Stock Holding History

Covington Capital Management’s Portfolio PACB Stock Details PACB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		$29K Hold
4,975
– – ﹤0.01% 651
2022
Q2 		$22K Hold
4,975
– – ﹤0.01% 691
2022
Q1 		$45K Hold
4,975
– – ﹤0.01% 597
2021
Q4 		$102K Buy
+4,975
New +$120K ﹤0.01% 443

Other funds holding PACB

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Covington Capital Management's PACB Position: Q3 2022 in Review

Covington Capital Management held its Pacific Biosciences (PACB) position steady in Q3 2022 at 4,975 shares worth $29K. The position accounts for ﹤0.01% of the portfolio, ranked #651.

Covington Capital Management first reported a position in PACB in Q4 2021 and has held it in 4 quarters since. The position peaked at $102K in Q4 2021. 227 funds tracked by Wall St. Rank hold PACB as of Q3 2022.

  • Covington Capital Management held 4,975 shares of Pacific Biosciences worth $29K as of Q3 2022.
  • Covington Capital Management left its Pacific Biosciences share count unchanged in Q3 2022.
  • Pacific Biosciences made up ﹤0.01% of Covington Capital Management's portfolio in Q3 2022, its #651 holding.
  • Covington Capital Management first reported a position in Pacific Biosciences in Q4 2021 and has held it in 4 quarters since.
  • Covington Capital Management's Pacific Biosciences position peaked at $102K in Q4 2021.
  • 227 funds tracked by Wall St. Rank held Pacific Biosciences as of Q3 2022.

Based on Covington Capital Management's 13F filing for Q3 2022, filed 15 Nov 2022.